Skip to content

Vericel VCEL Quick ratio

Quick ratio at other companies

Stryker logo
StrykerSYK
1.3×+0.3×
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
0.9×-0.5×
LeMaitre Vascular logo
LeMaitre VascularLMAT
14.3×-2.2×
Capricor Therapeutics logo
Capricor TherapeuticsCAPR
8.4×+1.9×
Globus Medical logo
Globus MedicalGMED
+0.2×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.8×-0.3×

Other financials

Income statement

See full
Revenue$68.4M+30.1%
Gross profit$49.3M+35.8%
Operating income-$8.1M+37.0%
Net income-$6.3M+44.0%
EPS (diluted)-$0.12+47.8%

Balance sheet

See full
Cash & equivalents$109.3M+37.1%
Total debt$95.0M-4.6%
Total equity$356.2M+20.6%
Total assets$485.6M+14.4%

Cash flow

See full
Operating cash flow$16.4M+148%
CapEx$1.3M-91.2%
Free cash flow$15.1M+299%

Valuation

See full
Market cap$2.13B-26.8%

Profitability

See full
Gross margin74.8%+2.3pp
Operating margin5.4%+4.6pp
Net margin7.3%+6.1pp
FCF margin16.3%

Returns & leverage

See full
Return on equity6.6%+5.5pp
Debt / equity0.3×-0.1×
Current ratio5.2×+0.2×

Where this comes from

Calculated from Vericel’s reported figures.

Based on the most recent quarter.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vericel's quick ratio?
Vericel (VCEL) reported quick ratio of 4.8× in Q1 2026.
How has Vericel's quick ratio changed year-over-year?
Vericel's quick ratio increased by 4.6% year-over-year, from 4.6× to 4.8×.
What is the long-term trend for Vericel's quick ratio?
Over 5 years (2020 to 2025), Vericel's quick ratio has grown at a -1.6% compound annual growth rate (CAGR), from 5.1× to 4.7×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.